Pfizer signs deal to let generic drug companies make its COVID-19 antiviral pill
Published
Although the drug hasn't yet been authorized anywhere, the arrangement with the Medicines Patent Pool could make it available to half the world's population in poor and middle-income countries if approved.
Full Article